Seeing Is Believing
Analyst Chris Cooper, currently employed at GOLDMAN SACHS,
Most recent stock forecast was given on RMD, ResMed at 20-Sep-2025.
Analyst best performing recommendations are on RMD (RESMED).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$270
$-0.14 (-0.05%)
$250
2 months 3 days ago
(16-Jul-2025)
12/12 (100%)
$15.75 (6.19%)
106
Hold
$248
$-22.14 (-8.20%)
$260
4 months 26 days ago
(24-Apr-2025)
3/3 (100%)
$11.9 (5.04%)
70
Buy
$285
$14.86 (5.50%)
$250
4 months 26 days ago
(24-Apr-2025)
6/6 (100%)
$48.9 (20.71%)
42
Buy
$290
$19.86 (7.35%)
$286
4 months 26 days ago
(24-Apr-2025)
18/18 (100%)
$53.9 (22.83%)
353
Hold
7 months 19 days ago
(31-Jan-2025)
11/11 (100%)
$-7.67 (-3.15%)
212